1st Quarter - Report

BECTON, DICKINSON AND COMPANY for BECTON DICKINSON AND COMPANY

Firm
Client
Income
—
Expenses
$220,000
Expense method
C: businesses, Internal Revenue Code section 162(e)

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

NIH Funding FDA Funding PEPFAR

LobbyistCovered position, as disclosed
JENNIFER M LURAY —
DANNY LY —
ELIZABETH WOODY —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

Healthcare policy and medical technology issues

LobbyistCovered position, as disclosed
JENNIFER M LURAY —
DANNY LY —
ELIZABETH WOODY —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Taxation/Internal Revenue Code TAX

H.R.523, Protect Medical Innovation Act of 2013 S.232, Medical Device Access and Innovation Protection Act Device tax amendment Corporate tax issues

LobbyistCovered position, as disclosed
JENNIFER M LURAY —
DANNY LY —
ELIZABETH WOODY —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 232 (113th), H.R. 523 (113th)

Medicare/Medicaid MMM

Diagnostic reimbursement

LobbyistCovered position, as disclosed
JENNIFER M LURAY —
ELIZABETH WOODY —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.